97 related articles for article (PubMed ID: 11057740)
21. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
22. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
23. Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh.
Wall NR; Mohammad RM; Reddy KB; Al-Katib AM
Int J Mol Med; 2000 Feb; 5(2):165-71. PubMed ID: 10639596
[TBL] [Abstract][Full Text] [Related]
24. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
Wall NR; Mohammad RM; Nabha SM; Pettit GR; Al-Katib AM
Biochem Biophys Res Commun; 1999 Dec; 266(1):76-80. PubMed ID: 10581168
[TBL] [Abstract][Full Text] [Related]
25. Bryostatin 5 induces apoptosis in acute monocytic leukemia cells by activating PUMA and caspases.
Wang Y; Zhang J; Wang Q; Zhang T; Yang Y; Yi Y; Gao G; Dong H; Zhu H; Li Y; Lin H; Tang H; Chen X
Eur J Pharmacol; 2013 Oct; 718(1-3):340-9. PubMed ID: 24036350
[TBL] [Abstract][Full Text] [Related]
26. Staurosporine modulates radiosensitivity and radiation-induced apoptosis in U937 cells.
Guo HR; Chen CH; Ho SY; Ho YS; Chen RJ; Wang YJ
Int J Radiat Biol; 2006 Feb; 82(2):97-109. PubMed ID: 16546908
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc.
Chelliah J; Freemerman AJ; Wu-Pong S; Jarvis WD; Grant S
Biochem Pharmacol; 1997 Sep; 54(5):563-73. PubMed ID: 9337072
[TBL] [Abstract][Full Text] [Related]
28. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W; Yacoub S; Shiverick KT; Namiki K; Sakai Y; Porvasnik S; Urbanek C; Rosser CJ
Prostate; 2008 Aug; 68(11):1223-31. PubMed ID: 18465755
[TBL] [Abstract][Full Text] [Related]
29. Modulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
Grant S
Front Biosci; 1997 Jun; 2():d242-52. PubMed ID: 9195893
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 and caspase-3 are major regulators in Agaricus blazei-induced human leukemic U937 cell apoptosis through dephoshorylation of Akt.
Jin CY; Moon DO; Choi YH; Lee JD; Kim GY
Biol Pharm Bull; 2007 Aug; 30(8):1432-7. PubMed ID: 17666799
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the mitogen activated protein kinase pathway potentiates radiation-induced cell killing via cell cycle arrest at the G2/M transition and independently of increased signaling by the JNK/c-Jun pathway.
Cartee L; Vrana JA; Wang Z; Park JS; Birrer M; Fisher PB; Grant S; Dent P
Int J Oncol; 2000 Feb; 16(2):413-22. PubMed ID: 10639586
[TBL] [Abstract][Full Text] [Related]
32. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
Vrana JA; Rao AS; Wang Z; Jarvis WD; Grant S
Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity.
Park JW; Choi YJ; Suh SI; Baek WK; Suh MH; Jin IN; Min DS; Woo JH; Chang JS; Passaniti A; Lee YH; Kwon TK
Carcinogenesis; 2001 Oct; 22(10):1633-9. PubMed ID: 11577002
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent.
Reiners JJ; Kessel D
Cancer Lett; 2005 Apr; 221(2):153-63. PubMed ID: 15808401
[TBL] [Abstract][Full Text] [Related]
35. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis.
Wang S; Wang Z; Boise L; Dent P; Grant S
Biochem Biophys Res Commun; 1999 May; 259(1):67-72. PubMed ID: 10334917
[TBL] [Abstract][Full Text] [Related]
36. Potentiation of 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial damage and apoptosis in human leukemia cells (U937) overexpressing bcl-2 by the kinase inhibitor 7-hydroxystaurosporine (UCN-01).
Tang L; Boise LH; Dent P; Grant S
Biochem Pharmacol; 2000 Nov; 60(10):1445-56. PubMed ID: 11020446
[TBL] [Abstract][Full Text] [Related]
37. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
38. Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells.
Huaying S; Dong Y; Chihong Z; Xiaoqian Q; Danying W; Jianguo F
Med Sci Monit; 2016 Dec; 22():5041-5048. PubMed ID: 28002389
[TBL] [Abstract][Full Text] [Related]
39. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.
Chen YJ; Wang JJ; Chang LS
Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174
[TBL] [Abstract][Full Text] [Related]
40. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells.
Jarvis WD; Povirk LF; Turner AJ; Traylor RS; Gewirtz DA; Pettit GR; Grant S
Biochem Pharmacol; 1994 Mar; 47(5):839-52. PubMed ID: 8135859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
